Manuel Ramos-Casals1,2,3,*, Anna Linda Zignego4, Clodoveo Ferri5, Pilar Brito-Zeron1,2,6, Soledad Retamozo1,7, Milvia Casato8, Peter Lamprecht9, Alessandra Mangia10, David Saadoun11,12,13,14, Athanasios G. Tzioufas15, Zobair M. Younossi16, Patrice Cacoub11,12,13,14, от имени экспертной группы ISG-EHCV†
1 Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Barcelona, Spain; 2 Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain; 3 Department of Medicine, University of Barcelona, Barcelona, Spain; 4 Interdepartmental Center MASVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 5 Chair and Rheumatology Unit, Medical School, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria, Policlinico di Modena, Modena, Italy; 6 Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA — Sanitas, Barcelona, Spain; 7 Rheumatology Department, Hospital Privado Universitario de Cordoba, INSTITUTO DE INVESTIGACIONES EN CIENCIAS DE LA SALUD (INICSA), National Scientific and Technical Research Council, CONICET — CORDOBA — Argentina; 8 Department of Clinical Immunology, Sapienza University of Rome, Italy; 9 Department of Rheumatology & Vasculitis Center, University of Lubeck, Germany; 10 Liver Unit, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy; 11 Sorbonne Universites, UPMC Universite Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), F-75005 Paris, France; 12 INSERM, UMR_S 959, F-75013 Paris, France; 13 CNRS, FRE3632, F-75005 Paris, France; 14 AP-HP, Groupe Hospitalier Pitie-Salpetriere, Department of Internal Medicine and Clinical Immunology, F-75013 Paris, France; 15 Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Greece; 16 Chairman, Department of Medicine, Inova Fairfax Medical Campus, Vice President for Research, Inova Health System, Professor of Medicine, VCU-Inova Campus, The Claude Moore Health Education and Research Center, Beatty Center for Integrated Research, Falls Church, VA, USA
Получено 10 ноября 2016; получено с поправками 5 февраля 2017 г.; принято в печать 6 февраля 2017 г.
† Список членов группы приведен в «Дополнительных материалах».
* Автор, ответственный за переписку. Адрес: Laboratory of Autoimmune Diseases Josep Font, CELLEX-IDIBAPS, Department of Autoimmune Diseases ICMiD, Hospital Clinic Barcelona, Spain. Tel.: +34 93 2275774; fax: +34 93 2271707.
E-mail: mramos@clinic. ub.es (M. Ramos-Casals)
Ключевые слова: гепатит С, внепеченочные проявления, ПППД, ритуксимаб.
Полный контент только для зарегистрированных пользователей сайта. Если Вы уже являетесь пользователем, пожалуйста, войдите в систему.